<DOC>
	<DOCNO>NCT01071291</DOCNO>
	<brief_summary>This study evaluate whether chronic dose Niaspan™ increase reverse cholesterol transport , high-density lipoprotein cholesterol ( HDL-C ) level , fecal excretion cholesterol .</brief_summary>
	<brief_title>Effects Niaspan™ High-density Lipoprotein ( HDL ) Healthy Male Subjects ( 0000-069 )</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>Healthy Male Subjects Exclusion Criteria : Subject history stroke , chronic seizure , major neurological disorder Subject history clinically significant endocrine , gastrointestinal , cardiovascular , hematological , hepatic , immunological , renal , respiratory , genitourinary abnormality disease</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>